Skip to main content
Premium Trial:

Request an Annual Quote

VA, Sanford Health to Offer Free PGx Testing to 250K Vets

NEW YORK (GenomeWeb) – The US Department of Veterans Affairs and Sioux Falls, South Dakota-headquartered healthcare system Sanford Health today announced they will provide pharmacogenetic testing to up to 250,000 veterans.

The program, which will provide PGx testing at no cost to veterans, is supported via a $25 million gift from philanthropist Denny Sanford. Sanford Health also fundraised matching contributions. The pilot program will launch at one site in Durham, North Carolina and will initially test vets who are cancer survivors. By 2022, the plan is to provide testing to 250,000 veterans and expand to 125 sites.

According to Deepak Voora, director of the VA PHASeR (Pharmacogenomics Action for Cancer Survivorship) Program and an associate professor at Duke University, this will be the largest PGx testing program in the country. The test results will be used to guide decisions about treatments for a variety of conditions, including mental health and cardiovascular diseases. The data collected within the program will also facilitate research.

Veterans will be able to get tested at their local VA facility. Sanford will analyse the results at its South Dakota Imagenetics facility. As the program expands, it will also include genetic counseling.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.